Kaplan-Meier curve analysis showed patients with FOXM1 expression above the median had significantly poorer survival compared to those with FOXM1 expression below the median, both in breast cancer (1115 patients, p=2.7e-07) (Supplementary Figure S2B) and lung cancer (1210 patients, p=3.2e-11) (Supplementary Figure S2C). Here, FOXM1 is linked to breast carcinoma.